Page 14 - Lon Gsk News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Lon gsk. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Lon Gsk Today - Breaking & Trending Today
GlaxoSmithKline (LON: GSK) recently received a number of ratings updates from brokerages and research firms: 4/20/2022 – GlaxoSmithKline had its “hold” rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft. They now have a GBX 1,500 ($19.52) price target on the stock. 4/19/2022 – GlaxoSmithKline was given a new GBX 2,100 ($27.32) price target on by […] ....
Barclays reissued their equal weight rating on shares of GlaxoSmithKline (LON:GSK – Get Rating) in a research report released on Monday, MarketBeat reports. The firm currently has a GBX 1,675 ($21.83) price objective on the stock. Several other brokerages have also recently commented on GSK. The Goldman Sachs Group set a GBX 2,000 ($26.06) target […] ....
GlaxoSmithKline (LON:GSK – Get Rating) received a GBX 1,790 ($23.48) price target from equities researchers at UBS Group in a research note issued to investors on Monday, Borsen Zeitung reports. UBS Group’s price target indicates a potential upside of 0.35% from the company’s current price. Other equities research analysts also recently issued research reports about […] ....
GlaxoSmithKline (LON:GSK – Get Rating)‘s stock had its “hold” rating reissued by research analysts at Deutsche Bank Aktiengesellschaft in a report released on Thursday, MarketBeat.com reports. They presently have a GBX 1,500 ($19.67) target price on the stock. Deutsche Bank Aktiengesellschaft’s price target would indicate a potential downside of 13.74% from the stock’s current price. […] ....
Shares of GlaxoSmithKline plc (LON:GSK – Get Rating) have earned a consensus rating of “Hold” from the fifteen analysts that are presently covering the firm, Marketbeat Ratings reports. Seven equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. The average 12 month target […] ....